According to Innovus Pharmaceuticals latest financial reports the cash on hand of INNV is $173.46M, an decrease of -5.95% to 2022. At the end of 2022 company had $184.43M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $173.46M | -5.95% |
2022 | $184.43M | -8.46% |
2021 | $201.47M | 78.44% |
2020 | $112.90M | 89.24% |
2019 | $59.66M | - |